General Director, Pharmstandard
Igor Krylov has been the General Director of Pharmstandard since 2003 (when the company was called ICN). He is responsible for elaborating and implementing the company’s strategy, as well as operational management of Pharmstandard holding. He is also coordinating the integration to the group of Masterlek, a producer of medical equipment, instruments and pharmaceuticals.
Previously, Mr. Krylov held management positions at the representative offices of Eli Lilly and Aventis Pharma. He is a graduate of the Kirov State Medical Institute.